I61 I63 I63.3 I63.4 I64 G45 F01 F01.1
Conditions
Interventions
Group 1: All individuals diagnosed with stroke (both hospitalized and non-hospitalized) will be followed up at several time points (baseline, after 3 months, after 12 months, annually) for the rest of
Sponsors
Friedrich-Alexander-Universität Erlangen-Nürnberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All cases of stroke defined according to WHO criteria, as “rapidly developing clinical symptoms and/or signs of focal, and at times global, loss of cerebral function, with symptoms lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin occurring in Erlangen, Bavaria No restrictions regarding age (provided they are of legal age), socioeconomic circumstance, stroke severity, or prior health status
Exclusion criteria
Exclusion criteria: Patients with transient episodes lasting less than 24 hours and those with asymptomatic lesions detected by brain imaging (“silent infarcts”)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The goal of ESPro is to establish a population-based stroke registry in order to determine key indicators (such as incidence and mortality) within a specific German population group (in accordance with the Helsingborg Declaration) as a basis for calculating future healthcare needs and planning future health policy. | — |
Countries
Germany
Contacts
Public ContactPeter L. Kolominsky-Rabas
Interdisziplinäres Zentrum für Health Technology Assessment und Public Health (IZPH) der FAU Erlangen-Nürnberg
Outcome results
None listed